Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Gift Director gave 29,580 shares (gift)
  5. 4 Exercise or conversion VP, Biology acquired 26,748 shares (option exercise)
  6. 4 Open-market buy Director bought 15,000 shares at $2.22 ($33,281)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 10,000 shares at $2.95 ($29,500)
  14. 4 Open-market buy Director bought 6,335 shares at an average $2.90 ($18,363)
  15. 4 Open-market buy Head, Translational Research bought 1,000 shares at $3.00 ($2,995)
  16. 4 Open-market buy SVP, Drug Discovery bought 10,000 shares at $2.48 ($24,824)
  17. 4 Open-market buy 10% owner bought 60,202 shares at an average $2.61 ($157,267)
  18. 4 Open-market buy Director bought 50,000 shares at $2.82 ($140,770)
  19. 4 Open-market buy Director bought 7,500 shares at $2.78 ($20,836)
  20. 4 Open-market buy CFO & COO bought 15,000 shares at an average $2.88 ($43,225)

Page 12 of 19 · 370 filings